Virtual Medicinal Product (VMP) - Crisantaspase 10,000unit powder for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Crisantaspase 10,000unit powder for solution for injection vials Start Date 18-05-2004 End Date
Previous Name Previous Name Crisantaspase 10,000unit injection vials Start Date 07-08-2003 End Date 17-05-2004
Abbreviated Name Abbreviated Name Crisantaspase 10,000unit inj vials Start Date 01-05-2009
Previous Abbreviated Name Crisantaspase 10,000unit pdr for soln for inj vials Previous Start Date 07-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous, Intramuscular, Subcutaneous
Form
Powder for solution for injection
Ontology Form/Route
solutioninjection.intravenous, solutioninjection.intramuscular, solutioninjection.subcutaneous
Name Basis
BAN - British Approved Name

Codes

ATC Code
L01XX02
BNF Start Date End Date
Current BNF 08010500 Start Date 04-04-2022 End Date
Previous BNF 08010500 Start Date 10-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39732911000001103 27-05-2021
327005002 07-08-2003 26-05-2021

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Crisantaspase Based on Ingredient Substance 10000 unit

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 vial
20 vial